NCT06377072View on ClinicalTrials.gov

Efficacy and Safety of Shenqi Sherong Pill in Participants With Cervical Spondylotic Myelopathy

PHASE3RecruitingINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

May 11, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

March 31, 2026

Conditions
Cervical Spondylotic Myelopathy
Interventions
DRUG

Shenqi Sherong Pill

two bags each time, three times a day at half an hour after breakfast, lunch and dinner for 6 weeks

DRUG

Placebo

two bags each time, three times a day at half an hour after breakfast, lunch and dinner for 6 weeks

Trial Locations (1)

510000

RECRUITING

Guangdong Provincial Hospital of Chinese Medicine, Guangzhou

All Listed Sponsors
lead

Shanghai Hutchison Pharmaceuticals Limited

INDUSTRY